Loading...
Home 2017-11-16T15:35:26+00:00

BIOMIMETIC GLUCOSE BINDING MOLECULES

Our mission is to help people with diabetes to live more normal and longer lives. We are using our proprietary Biomimetic Glucose Binding Molecules (GBM) to help enable our partners to make the next generation of Continuous Glucose Monitors (CGM) and Glucose Responsive Insulins (GRI).

SELECTIVE MONITORING

Our GBMs offer unparalleled selectivity towards glucose and function in even the most complex biological mixtures.

STABLE & VERSATILE

Our GBMs are extremely robust with a multi-year operational potential.

SCALABLE PLATFORM

Ziylo’s GBMs are produced by a streamlined, scalable synthesis and are readily derivatised for bioconjugation and chemical synthesis.

ABOUT ZIYLO

Ziylo is a supramolecular chemistry company that has developed a third ‘biomimetic’ class of glucose binding molecule (GBM). These molecules are at the core of medical devices such as Continuous Glucose Monitors (CGM) and therapeutics such as Glucose Responsive Insulins (GRI). Our platform technology is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis’ group at the University of Bristol. Inspired by nature’s carbohydrate-binding molecules (lectins), Professor Davis has become a leader in the field of ‘Synthetic Lectins’ – biomimetic molecules that are capable of binding carbohydrates like glucose in water. This award-winning chemistry has been published in Science and Nature Chemistry and has laid the foundation for the discovery our Biomimetic GBM platform.

The latest instalment of 'The Science Behind the Technology' is online now. This month we spoke to Charlotte of @VitamicaAMR on their tech, which could speed up antibiotic screening in hospitals and assist in the fight against antimicrobial resistance. https://t.co/mNTmRTtRH7

The latest instalment of 'The Science Behind the Technology' is online now. This month we spoke to Charlotte of @VitamicaAMR on their tech, which could speed up antibiotic screening in hospitals and assist in the fight against antimicrobial resistance. https://t.co/mNTmRTtRH7

Fantastic experience in #Parliament today talking #science #bristol with @ThangamMP and #UnitDX - time to find the a building!

Fantastic experience in #Parliament today talking #science #bristol with @ThangamMP and #UnitDX - time to find the a building!

Its a wrap! A very interesting discussion around innovation infrastrucure and encouraging the next generation of scientists in Bristol. Its great to mark one year since our opening with a huge increase in the numbers of spin-outs being formed in the city. More news on this soon!

Its a wrap! A very interesting discussion around innovation infrastrucure and encouraging the next generation of scientists in Bristol. Its great to mark one year since our opening with a huge increase in the numbers of spin-outs being formed in the city. More news on this soon!

We are en route to @visitparliament for our event today, celebrating one year since our opening. Many thanks to @ThangamMP for hosting!

We are en route to @visitparliament for our event today, celebrating one year since our opening. Many thanks to @ThangamMP for hosting!

Our latest newsletter is online now. This issue includes an interview with Unit DX members Innaxon on their technology, which can dampen or support immune responses - https://t.co/L1MYUgta23

Our latest newsletter is online now. This issue includes an interview with Unit DX members Innaxon on their technology, which can dampen or support immune responses - https://t.co/L1MYUgta23
Load More...